Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia
Open Access
- 2 November 2018
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 60 (6) , 837-843
Abstract
The predictive value of 18F-fluorodeoxyglucose (FDG) PET for conversion from mild cognitive impairment (MCI) to Alzheimer’s dementia (AD) is currently under debate. We used a principal component analysis (PCA) to identify a metabolic AD conversion-related pattern (ADCRP) and investigated the prognostic value of the resulting pattern expression score (PES). Methods: FDG PET scans of 544 MCI patients obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database were analyzed. We implemented voxel-based PCA and standard SPM (as reference) analyses to disclose cerebral metabolic patterns associated with conversion from MCI to AD. By Cox proportional hazards regression we examined the prognostic value of candidate predictors. Also, we constructed prognostic models with: i) clinical, ii) imaging, and iii) clinical and imaging variables in combination. Results: PCA revealed an ADCRP that involved regions with relative decrease in metabolism (temporoparietal, frontal, posterior cingulate and precuneus cortex) and relative increase in metabolism (sensorimotor and occipital cortex, cerebellum and left putamen). Among the predictor variables age, sex, functional activities questionnaire (FAQ), mini-mental state examination (MMSE), apolipoprotein E (APOE), PES and normalized FDG uptake (regions with significant hypo- and hypermetabolism in converters compared to non-converters), PES was the best independent predictor of conversion (Hazard Ratio = 1.77 per z-score increase, 95% C.I.: 1.24 - 2.52, p < 0.001). Moreover, adding PES to the model including the clinical variables significantly increased its prognostic value. Conclusions: The ADCRP expression score is a valid predictor of conversion. Combining clinical variables and PES yielded a higher accuracy than each single tool in predicting conversion of MCI to AD, underlining the incremental utility of FDG PET.Keywords
This publication has 31 references indexed in Scilit:
- Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer’s dementia in a memory clinic populationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Early identification of MCI converting to AD: a FDG PET studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectivesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- 18F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Cochrane Database of Systematic Reviews, 2015
- Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementiaNeurobiology of Aging, 2014
- Principal component analysis of FDG PET in amnestic MCIEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Multivariate and univariate neuroimaging biomarkers of Alzheimer's diseaseNeuroImage, 2008
- Abnormal metabolic networks in atypical parkinsonismMovement Disorders, 2008
- Neuropathologic Features of Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2006
- The Cox Model2000